Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


VENTAS INC   FYE=12 (December)

Annual - Income Statement - Company Specific

Fiscal period2020201920182017201620152014201320122011
Period End Date12/31/202012/31/201912/31/201812/31/201712/31/201612/31/201512/31/201412/31/201312/31/201212/31/2011
Rental income--------------------
Rental income : Triple-net leased695.27780.90737.80840.13845.83779.80674.55586.02819.88627.72
Rental income : Medical office buildings799.63828.98776.01753.47630.34566.25463.91450.34360.85166.08
Resident fees and services2,197.162,151.532,069.481,843.231,847.311,811.261,552.951,406.011,227.12865.80
Interest income from loans receivable--------------------
Interest and other income7.6110.9824.896.030.881.054.262.021.111.22
Gain on sale of Kindred Healthcare, Inc. common stock--------------------
Medical office building services revenue15.1911.1613.4213.6821.0741.4929.3617.8120.7436.47
Income from loans and investments80.5189.20124.22117.6198.0986.5551.7854.4339.9134.42
Total Revenues3,795.363,872.753,745.813,574.153,443.523,286.402,776.812,516.622,469.621,731.70
Rent reset costs--------------------
Property-level operating expenses--------------------
Medical office buildings256.61260.25243.68233.01191.78174.23158.83153.24125.4056.99
Medical office building services costs2.322.321.423.397.3126.5717.098.329.8827.08
Property-level operating expenses: Triple-net leased22.1626.56----------------
Depreciation and amortization1,109.761,045.62919.64887.95898.92894.06725.22629.91714.97444.19
Amortization of restricted stock grants--------------------
Stock-based compensation--------------------
General, administrative and professional fees (including non-cash stock-based compensation expense of $1,820 and $727 fo130.16158.73145.98135.49126.88128.04121.74115.0898.5174.54
Professional fees--------------------
Non-recurring employee severance costs--------------------
Senior living(1,658.67)(1,521.40)(1,446.20)(1,250.07)(1,242.98)(1,209.42)(1,036.56)(956.68)(841.02)(588.10)
Litigation proceeds, net------------------202.26
Interest469.54451.66442.50448.20419.74367.11292.07249.01288.72223.80
Interest on United States settlement--------------------
Loss on impairment of assets--------------------
Merger-related expenses(29.81)(15.24)(30.55)(10.54)(24.64)(102.94)(43.30)(21.63)(63.18)(153.92)
Loss on extinguishment of debt(10.79)(41.90)(58.25)(0.75)(2.78)(14.41)(5.56)(1.20)(37.64)(27.60)
Gain on sale of Kindred Healthcare, Inc. common stock--------------------
Other(0.71)10.34(72.77)(20.05)(9.99)(17.96)(25.74)(17.36)(6.94)(7.27)
Foreign currency gain--------------------
Reversal of contingent liability--------------------
Net gain on swap breakage--------------------
Net proceeds from litigation settlement--------------------
Contribution to charitable foundation--------------------
United States Settlement--------------------
Loss on uncollectible amounts due from tenants--------------------
Allowance on loans receivable and investments(24.24)------------------
Income (loss) before provision (benefit) for income taxes, gain on disposal of real estate assets, discontinued operatio80.59359.42384.83584.71518.51351.68350.70364.18283.35330.47
Provision (Benefit) for income taxes(96.53)(56.31)(39.95)(59.80)(31.34)(39.28)(8.73)(11.83)(6.28)(30.66)
Current------(2.25)(0.68)2.541.21--1.21(4.08)
Deferred------(57.55)(30.66)(41.83)(9.94)--(7.49)(26.58)
Loss from unconsolidated entities1.84(2.45)(55.03)(0.56)4.36(1.42)(0.14)(0.51)18.15(0.05)
Net loss on real estate disposals262.2226.0246.25717.2798.20----------
Income from continuing operations441.19439.30415.991,361.22652.41389.54359.30375.50307.79361.08
Discontinued operations0.000.00(0.01)(0.11)(0.92)11.1099.7479.1753.992.19
Income (loss) before extraordinary loss--------------------
Extroardinary Income (Loss)--------------------
Gain on real estate dispositions----------18.5817.97------
Net income (loss)441.19439.30415.981,361.11651.49419.22477.00454.67361.78363.26
Noncontrolling interest, net of tax2.046.286.514.642.261.381.231.16(1.03)(1.23)
Preferred stock dividends and issuance costs--------------------
Net income(Loss) available to common stockholders439.15433.02409.471,356.47649.23417.84475.77453.51362.80364.49
Income from continuing operations applicable to common shares1.181.201.173.831.891.181.281.281.061.59
EPS (Basic) : Income from discontinued operations------------0.340.270.180.01
Extraordinary loss on extinguishment of debt--------------------
Net Earnings Per Share (Basic)1.181.181.153.821.881.261.621.551.241.60
Income from continuing operations applicable to common shares1.171.191.163.801.871.171.261.271.051.57
EPS (Diluted) : Income from discontinued operations------------0.340.270.180.01
Extraordinary loss on extinguishment of debt--------------------
Net Earnings Per Share (Diluted)1.171.171.143.781.861.251.601.541.231.58
Weighted Average Shares Outstanding (Basic)373.37365.98356.27355.33344.70330.31294.18292.65292.06228.45
Weighted Average Shares Outstanding (Diluted)376.50369.89359.30358.57348.39334.01296.68295.11294.49230.79
Funds from operations (FFO)1,269.261,436.051,308.151,512.891,440.541,365.411,273.681,208.461,024.57824.85